GeneFerm Biotechnology Co., Ltd. (TPEX:1796)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
37.55
-0.80 (-2.09%)
May 8, 2026, 1:30 PM CST
Market Cap1.56B -25.0%
Revenue (ttm)663.87M +16.6%
Net Income15.70M
EPS0.38
Shares Out41.46M
PE Ratio99.16
Forward PEn/a
Dividend0.70 (1.86%)
Ex-Dividend Daten/a
Volume51,000
Average Volume20,410
Open38.40
Previous Close38.35
Day's Range37.55 - 38.40
52-Week Range33.65 - 67.10
Beta0.10
RSI40.95
Earnings DateMay 11, 2026

About GeneFerm Biotechnology

GeneFerm Biotechnology Co., Ltd. develops, manufactures, and sells fermented health products in Taiwan and internationally. The company provides microbial fermentation products, including fungi, bacteria, lactic acid bacteria, yeast, algae, etc.; bio fermented ingredients, such as nattomena, natto fermented powder, red yeast rice fermented powder, antrodia cinnamomea mycelia powder, cordyceps, reishi mycelia, phellinus linteus mycelia powder, armillaria mellea mycelia powder, beta-glucan powder, and fruits and vegetables fermented enzyme, as we... [Read more]

Sector Healthcare
Founded 1999
Employees 144
Stock Exchange Taipei Exchange
Ticker Symbol 1796
Full Company Profile

Financial Performance

Financial Statements